Additionally, PFKFB3 inhibitors triggered cell cycle arrest of breast cancer cells in G2 phase, suggesting that inhibition of PFKFB3 could prevent cancer cells from proliferation. This evidence concerns the gene PFKFB3 and breast cancer.